Growth Metrics

Catalyst Pharmaceuticals (CPRX) EPS (Basic) (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Catalyst Pharmaceuticals 3.82 Bn 3.07 Bn 134.92 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 20.93%
Dec 31, 2025 0.00%
Sep 30, 2025 0.00%
Jun 30, 2025 -8.51%
Mar 31, 2025 2.17%
Dec 31, 2024 24.32%
Sep 30, 2024 5.71%
Jun 30, 2024 75.00%
Mar 31, 2024 -39.39%
Dec 31, 2023 213.79%
Sep 30, 2023 -180.56%
Jun 30, 2023 28.57%
Mar 31, 2023 16.67%
Dec 31, 2022 9.09%
Sep 30, 2022 4.76%
Jun 30, 2022 61.54%
Mar 31, 2022 44.44%
Dec 31, 2021 -10.00%
Sep 30, 2021 -16.67%
Jun 30, 2021 71.43%
Mar 31, 2021 -36.36%
Dec 31, 2020 -73.81%
Sep 30, 2020 366.67%
Jun 30, 2020 -10.00%
Mar 31, 2020 25.00%
Dec 31, 2019 -38.46%
Sep 30, 2019 18.18%
Jun 30, 2019 1,200.00%
Mar 31, 2019 92.86%
Dec 31, 2018 -75.00%
Sep 30, 2018 -33.33%
Jun 30, 2018 0.00%
Mar 31, 2018 0.00%
Dec 31, 2017 -20.00%
Sep 30, 2017 0.00%
Jun 30, 2017 16.67%
Mar 31, 2017 -20.00%
Dec 31, 2016 0.00%
Sep 30, 2016 16.67%
Jun 30, 2016 14.29%
Mar 31, 2016 0.00%
Dec 31, 2015 -40.00%
Sep 30, 2015 16.67%
Jun 30, 2015 14.29%
Mar 31, 2015 -40.00%
Dec 31, 2014 28.57%
Sep 30, 2014 -40.00%
Jun 30, 2014 28.57%
Mar 31, 2014 -133.33%
Dec 31, 2013 76.92%
Sep 30, 2013 -62.50%
Jun 30, 2013 -100.00%
Mar 31, 2013 -1,468.62%
Dec 31, 2012 96.81%
Sep 30, 2012 -700.00%
Jun 30, 2012 75.00%
Mar 31, 2012 60.00%
Dec 31, 2011 -100.00%
Sep 30, 2011 16.67%
Jun 30, 2011 25.00%
Mar 31, 2011 -100.00%
Dec 31, 2010 20.00%